Archive for the ‘Gene Therapy Research’ Category

Compact Scope
Get a great deal here redirect.viglink.com?key=1f0527e04637dcdb26bf99b11836bfbf out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB005CYX8QC Product Description Compact Scope Product Description Objective 32mm Magnification: 1.5x-5x Tube Diameter: 1" Parallax Setting: 100 Reticle Type: Range Finder Field of View (ft @ 100 yds): 32.0-11.0 Eye Relief (in): 3.3 Exit Pupil (mm): 7.0-3.6 Weight (oz): 15.5 Length (in): 13.0 Battery: CR2032 3V W/E Click Value @ 100 yds 1/4"OverviewSuperior multi-coated optics sets the sniper line of scopes apart from the competition without costing you an arm and a leg. Comparable if not the same as the manufacturing process to that of the Japanese and German optics. A hint of yellowish tint can be found on most Chinese optics offered by companies such as NcStar, Aimsports, Leapers, and Barska. Sniper line of scope is crystal clear and full of useful features such as quick windage/elevation locking adjustment plate.Sniper offers not a limited lifetime warranty (as stated, you are limited to conditions in fine prints) but a 100% satisfaction guaranty on the workmanship and against any manufacturer #39;s defect.Rule the game with your new sniper scope.1.5-5x32 CQB Close Quarter Combat scope with Laser illuminating designator. Light up the night with FSI compact rifle or pistol laser illuminating designator. Instant night vision for hunting, nature watching, or SOS beacon. Rule the night with FSI laser illuminating designator. Comparable to BSA Laser Genetics.From:lucile franciscoViews:0 0ratingsTime:00:53More inScience Technology

More here:
Compact Scope - Video

An Introduction to Genetics
I great short video to show in your classroom to introduce Students to genetics. I thought of this video based on Georgia Perfomance Standard S7L3.From:smadrid1187Views:1 0ratingsTime:03:21More inEducation

See the original post here:
An Introduction to Genetics - Video

Creatures 4 - GangNorn Style (PC, MAC, iPad, iPhone, Android - Soon!)
Instagram Sneak Peek Feed: instagram.com Norns Club @ Pinterest: pinterest.com Creatures 4 is the first and only Genetics Video Game series. After getting viewed over 1 billion times down on Earth, Psy #39;s intergalactic hit Gangnam Style has now reached Sphericus, the planet where the cute intelligent Norns race (tries to) live. Hatch eggs, breed creatures, pet them, educate them, feed them, nurture them, teach them, play with their genomes, mate them through the splicing machine or through natural means, do whatever you have to do to save the endangered species from extinction and repopulate the planet -- Tinker with evolution and balance the eco-system over generations! Each and every Norn created in the game is almost as unique as a human being: over a billion customization combination possibilities! Creatures 4 is a true Simulation of Life. Coming Spring 2013 on PC, MAC, iPad, iPhone, iPod, iPad Mini Android devices. Facebook: http://www.facebook.com Twitter: twitter.comFrom:FishingCactusGamesViews:2 0ratingsTime:00:52More inGaming

Read more here:
Creatures 4 - GangNorn Style (PC, MAC, iPad, iPhone, Android - Soon!) - Video

Genetic Research Project: Neurofibromatosis
Here is my presentation on Neurofibromatosis, and here are my references, shown here in the dooblydoo: Erb, MH, Uzcategui, N., See, RF, Burnstine, MA (2007). Orbitotemporal Neurofibromatosis: Classification and Treatment. Orbit, 223-228. Huijbregts, SC, de Sonneville, LM (2011). Does Cognitive Impairment Explain Behavioral and Social Problems of Children with Neurofibromatosis Type 1? Behaviour Genetics, 430-436. MedlinePlus. (2012, October 25). Neurofibromatosis. Retrieved from MedlinePlus: http://www.nlm.nih.gov Office of Communications and Public Liason. (2012, January 13). Neurofibromatosis Information Page. Retrieved from National Institute of Neurological Disorders and Stroke: http://www.ninds.nih.govFrom:boredoutofmymindizeViews:0 1ratingsTime:04:13More inEducation

Read the original:
Genetic Research Project: Neurofibromatosis - Video

Seed Company Showcases New Technology
In the following video, Jacob Bates, AgriGold regional agronomist, highlights some of the company #39;s new and existing genetics that farmers can tap into for 2013.From:AgWebSaraViews:1 0ratingsTime:02:28More inEntertainment

See original here:
Seed Company Showcases New Technology - Video

Founder effect
For more information, log on to- shomusbiology.weebly.com Download the study materials here- shomusbiology.weebly.com This video discusses the mechanism of founder effect which is an example of genetic drift. In population genetics, the founder effect is the loss of genetic variation that occurs when a new population is established by a very small number of individuals from a larger population. It was first fully outlined by Ernst Mayr in 1942,[1] using existing theoretical work by those such as Sewall Wright.[2] As a result of the loss of genetic variation, the new population may be distinctively different, both genetically and phenotypically, from the parent population from which it is derived. In extreme cases, the founder effect is thought to lead to the speciation and subsequent evolution of new species. In the figure shown, the original population has nearly equal numbers of blue and red individuals. The three smaller founder populations show that one or the other color may predominate (founder effect), due to random sampling of the original population. A population bottleneck may also cause a founder effect even though it is not strictly a new population. The founder effect is a special case of genetic drift.[3][4] In addition to founder effects, the new population is often a very small population and so shows increased sensitivity to genetic drift, an increase in inbreeding, and relatively low genetic variation. This can be observed in the limited gene pool of ...From:Suman BhattacharjeeViews:0 0ratingsTime:02:33More inEducation

Excerpt from:
Founder effect - Video

Marijuana LED Grow Week 5 6 Flower - LBK KH Flowering - Germinating Poison Genetics + FREEBIES
In this update video you will be able to see week five bloom update pics, week six bloom update pics, the lady berry kush and kushy haze after a couple weeks in flower, the germination of the latest 4 strains including Poison Genetics Casey #39;s Cousin x Sour Diesel IBL. So far these growblu.com LED GROW LIGHTS have performed GREAT!!!From:ledgrowshowsViews:0 0ratingsTime:02:47More inScience Technology

Here is the original post:
Marijuana LED Grow Week 5

Flu During Pregnancy Can Lead To Autism In Child NEW STUDY
Flu During Pregnancy Can Lead To Autism In Child NEW STUDY Doctors trying to find some of the causes of autism put another piece into the puzzle on Monday: They found women who had flu while they were pregnant were twice as likely to have a child later diagnosed with autism. Those who had a fever lasting a week or longer -- perhaps caused by flu or maybe by something else -- were three times as likely to have an autistic child. The study of 96000 children in Denmark raises as many questions as it answers. But it fits in with a growing body of evidence that suggests that, in at least some cases, something is going on with a mother #39;s immune system during pregnancy that affects the developing child #39;s brain. Health officials said the finding reinforces their recommendations that pregnant women should make sure to get flu shots. Advertise | AdChoices Autism seems to be a growing problem in the United States. According to the US Centers for Disease Control and Prevention, autism spectrum disorder affects one in 88 children, including about one in 54 boys. The autism spectrum refers to a broad range of symptoms, from the relatively mild social awkwardness of Asperger #39;s syndrome to profound mental retardation, debilitating repetitive behaviors and an inability to communicate. Scientists agree that it #39;s not just a matter of better diagnosis; the numbers seem to be growing because more children are indeed developing autism. But no one is sure why. Genetics are a large factor -- if ...From:HotBlockNewsViews:0 0ratingsTime:01:30More inNews Politics

Read this article:
Flu During Pregnancy Can Lead To Autism In Child NEW STUDY - Video

Gene flow
For more information, log on to- shomusbiology.weebly.com Download the study materials here- shomusbiology.weebly.com In this video lecture, I am going to talk about the gene flow among species and its importance to produce variations as well. In population genetics, gene flow (also known as gene migration) is the transfer of alleles or genes from one population to another. Migration into or out of a population may be responsible for a marked change in allele frequencies (the proportion of members carrying a particular variant of a gene). Immigration may also result in the addition of new genetic variants to the established gene pool of a particular species or population. There are a number of factors that affect the rate of gene flow between different populations. One of the most significant factors is mobility, as greater mobility of an individual tends to give it greater migratory potential. Animals tend to be more mobile than plants, although pollen and seeds may be carried great distances by animals or wind. Maintained gene flow between two populations can also lead to a combination of the two gene pools, reducing the genetic variation between the two groups. It is for this reason that gene flow strongly acts against speciation, by recombining the gene pools of the groups, and thus, repairing the developing differences in genetic variation that would have led to full speciation and creation of daughter species. For example, if a species of grass grows on both sides ...From:Suman BhattacharjeeViews:0 0ratingsTime:02:29More inEducation

The rest is here:
Gene flow - Video

Star Visitors - Dr. Richard Boylan - Coast to Coast AM Classic
http://www.jetnews.us Date: 02-03-11 Host: George Noory Guests: Dr. Richard J. Boylan, Joshua P. Warren Appearing in the second hour, anthropologist specializing in Star Cultures, and certified clinical hypnotherapist, Dr. Richard Boylan shared updates on ET visitors and #39;star children. #39; According to his information, a powerful ruling cabal plans to conduct a fake alien invasion, to divert attention away from their oppressive tactics. The recent UFO sighting in Jerusalem is an example of this, he added. Humans were bio-engineered by ETs 275000 years ago, and they continue to upgrade human genetics, with some 96% of grade school children being "star seeds" or "star children," he cited. There are some 1483 separate alien races who have visited Earth, including two groups that reside here-- the Tall Whites in Nevada, and the Saami people who came from Barnard #39;s star, and now live above the Arctic Circle, he claimed. Opens Lines Joshua P. Warren The latter half of the show featured Open Lines, with callers sharing accounts that included encounters with small aliens, and the Old Hag. Paranormal investigator Joshua P. Warren joined George to field the calls in the last hour, and related how he was saved during an angelic intervention as a young boy. He also commented that humans may be developing a new sensory organ that will allow them to view astral entities around us. Biography: Dr. Richard J. Boylan is a Ph.D. behavioral scientist, anthropologist, University associate professor ...From:C2CPlanetViews:24 1ratingsTime:01:55:01More inEducation

Read more here:
Star Visitors - Dr. Richard Boylan - Coast to Coast AM Classic - Video

Hardy Weinberg equilibrium
For more information, log on to- shomusbiology.weebly.com Download the study materials here- shomusbiology.weebly.com This video tutorial explains the Hardy-Weinberg equilibrium and its importance in population genetics studies.From:Suman BhattacharjeeViews:0 0ratingsTime:17:18More inEducation

Read the original:
Hardy Weinberg equilibrium - Video

Why descendants of "Black African Eve" look so different? (Evolution biology)
Human skin color is primarily due to the presence of melanin in the skin. Skin color ranges from almost black to white with a pinkish tinge due to blood vessels underneath. Variation in natural skin color is mainly due to genetics, although the evolutionary causes are not completely certain. According to scientific studies, natural human skin color diversity within populations is highest in Sub-Saharan African populations,[2] with skin reflectance values ranging from 19 to 46 (med. 31) compared with European and East Asian populations which have skin reflectance values of 62 to 69 and 50 to 59 respectively. The term "range" is loosely defined in this case, as African albinos have obviously not been taken into consideration when calculating the "range". The natural skin color can be darkened as a result of tanning due to exposure to sunlight. The leading theory is that skin color adapts to intense sunlight irradiation to provide partial protection against the ultraviolet fraction which produces damage and thus mutations in the DNA of the skin cells. Other factors that can modify skin color include protection from ambient temperature, infections, skin cancer or frostbite, an alteration in food, and sexual selection. The social significance of differences in skin color has varied across cultures and over time, as demonstrated with regard to social status and racism. About 70000--100000 years ago some modern humans began to migrate away from the tropics to the north where ...From:saddoboxing1Views:0 0ratingsTime:05:30More inScience Technology

See original here:
Why descendants of "Black African Eve" look so different? (Evolution biology) - Video

Four researchers from the Shafallah Medical Genetics Center (SMGC) have participated in an international human genetics meeting in San Francisco, California, USA to present the findings of their research projects in Qatar. The meeting is the 62nd annual meeting of the American Society of Human Genetics. It was held between November 6-10. It is the largest human genetics meeting and exposition in the world. It attracted about 7,000 scientific attendees and more than 200 exhibiting companies. American Society of Human Genetics members and leading scientists from around the world are selected to present their research findings at invited platform or poster sessions, during a 5 day packed programme. In addition, exhibitors show state-of-the-art medical and laboratory equipment, products, services and computer software designed to enhance human genetics research, teaching and diagnostics. The four researchers presented five posters that reflect on the research activities they had performed at SMGC in Doha. Two posters reported on gene discovery in two rare genetic conditions. One condition is found in one Qatari family and is related to mental retardation and multiple birth defects. The other condition represents a skin disease associated with a kidney defect with abnormal skin and low potassium levels in the blood of patients. A third poster reflects on the advances in bioinformatics tools that were adopted by SMGC to analyse large sets of genomic data. Two posters identify novel mutations in previously described genes and their relation to specific genetic disorders. Hassan Ali bin Ali, the chairman of the Shafallah Center, said: The researchers contribution to and participation at the American Society of Human Genetics meeting demonstrated the SMGC is now a world class genetics center that not only serves and helps the children at Shafallah, but contributes to the advancement of scientific knowledge on a global basis. The staff work very hard and it is encouraging to know that their research produces meaningful and positive outcomes.

Visit link:
Genetics Center takes part in global meet

LOS ANGELES, Nov. 13, 2012 /PRNewswire/ --Response Genetics, Inc. (RGDX), a company focused on the development and sale of molecular diagnostic tests for helping determine a patient's response to cancer therapy, today announced its consolidated financial results for the third quarter ended September 30, 2012.

Total revenues for the quarter ended September 30, 2012 increased to $5.40 million, compared to $3.84 million for the quarter ended June 30, 2012 and $5.10 million for the quarter ended September 30, 2011. The Company's pharmaceutical client revenue increased by $1.37 million and the ResponseDX revenue increased by $189 thousand relative to the quarter ended June 30, 2012.

The Company's net loss for the quarter ended September 30, 2012 decreased by $1.3 million to $1.4 million compared to a net loss of $2.7 million for the quarter ended June 30, 2012 and a net loss of $1.4 million for the quarter ended September 30, 2011. This is the third consecutive quarter the Company decreased its net loss.

The Company also increased its gross margin in three consecutive quarters from approximately 25% for the fourth quarter of 2011, to approximately 32% for the quarter ended March 31, 2012 to approximately 37% for the quarter ended June 30, 2012, to approximately 49% for the quarter ended September 30, 2012. Gross margin is Net Revenue less Cost of Revenue.

Excluding cost of revenue, total operating expenses for the third quarter were $4.0 million, compared to $4.1 million for the quarter ended June 30, 2012 and $4.0 million for the same period last year.

"We are very pleased with the financial results for the quarter ended September 30, 2012, which improved again relative to the prior quarter. Since the fourth quarter of last year, we continued to realize consecutive quarter-over-quarter positive results from the many changes implemented by the Company. Gross margins have increased nearly two-fold from the fourth quarter of last year, and operating loss has continued to decrease significantly, or nearly two-fold, since last quarter and by a factor of nearly 2.8 from the fourth quarter of last year," said Thomas Bologna, the Company's Chairman & Chief Executive Officer.

Total revenues for the nine months ended September 30, 2012 were $13.2 million compared to $17.7 million for the nine months ended September 30, 2011. The decrease is largely a result of the expected decrease in pharmaceutical client revenue of $3.9 million from $8.3 million for the nine months ended September 30, 2011 to $4.4 million for the nine months ended September 30, 2012. Additionally, early in 2012, the Company made the strategic decision to focus much of its pharmaceutical resources on working with GSK as it moves its drugs, for which the Company did extensive patient testing, through the FDA approval process. The Company's ResponseDX revenue was $8.8 million for the nine months ended September 30, 2012, compared to $9.4 million for the nine months ended September 30, 2011, largely as a result of tactical changes the Company is undergoing in building and directing its sales force.

The Company's net loss for the nine months ended September 30, 2012 was $7.3 million, compared with a net loss of $1.8 million for the nine months ended September 30, 2011.

Excluding cost of revenue, total operating expenses for the nine months were $12.5 million, compared to $11.4 million for the same period last year. The increase in total operating expense of $1.1 million was due to an increase in general and administrative expenses of $0.2 million and an increase in research and development expenses of $0.9 million.

The Company's cash position increased substantially to $10.8 million at September 30, 2012 compared to $2.6 million at June 30, 2012.

Link:
Response Genetics, Inc. Announces Third Quarter Financial Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--

Insight Genetics, Inc. today announced it has received two Small Business Innovation Research (SBIR) contracts from the National Cancer Institute (NCI) to continue its work developing diagnostic tests that identify and characterize specific genetic mutations in lung cancer patients. These companion diagnostic tests will be vital tools in enhancing the accuracy of cancer diagnosis and treatment, assisting physicians in determining which targeted cancer therapies are appropriate for specific patients.

Insight Genetics received a $1,495,220 Phase II contract to further develop its proprietary Insight ALK Screen that detects the complete spectrum of oncogenic anaplastic lymphoma kinase (ALK) mutations and fusions, which are associated with several types of cancer including non-small cell lung cancer (NSCLC). NCI also awarded the company a Phase I Fast Track contract of $199,576 to support research and development of a panel of companion diagnostic tests for the detection of RET, ROS1 and DEPDC1 mutations in NSCLC.

As part of its Phase II ALK contract, Insight Genetics will continue analytical and clinical validation of Insight ALK Screen, a real-time qPCR-based test being developed on a QIAGEN platform.

ALK fusions and mutations have been shown to be a contributing cause in approximately 5-10 percent of lung cancers. With knowledge of a patients ALK status, clinicians can more accurately determine if the patient will respond to ALK-inhibitor therapies, an emerging class of cancer treatments. Since only patients with ALK fusions are likely to respond to ALK inhibitors, accurate diagnostic screening is essential before prescribing ALK-targeted drugs.

Insight ALK Screen is more sensitive and specific than the other ALK detection methods currently available, said David Hout, Ph.D., Insight Genetics vice president of research and development. Our test will reduce false-negative calls of ALK status in tumors, which means more patients who may benefit from ALK inhibitor therapies will receive these targeted treatments. Since it is more easily and quickly performed than alternative tests, Insight ALK Screen also will provide actionable information to physicians and their patients in a more timely manner.

The Phase I Fast Track contract addresses a significant unmet medical need in the diagnosis and treatment of NSCLC. Collectively, RET, ROS1 and DEPDC1 mutations have been estimated to constitute up to 9 percent of all NSCLC cases, but, at present, there are no regulatory-approved, high-throughput commercial diagnostic tests that can reliably and efficiently identify these biomarkers. The Phase I contract funds nine months of work to create a panel test, with the potential to continue into Phase II funding totaling $1,499,412.

This new NCI contract allows our team to research and develop a panel of assays that detect the presence of oncogenic RET and ROS1 fusions, along with DEPDC1 expression, continued Hout. Effectively identifying these biomarkers is the only way to ensure that patients who carry them can benefit from targeted cancer therapies.

Various therapies targeting RET and ROS1, respectively, have shown good efficacy in clinical trials. Two examples are Bayers Nexavar (sorafenib) for RET and Pfizers Xalkori (crizotinib) that inhibits ROS1 as well as ALK.

These two new contracts are the third and fourth companion diagnostic awards Insight Genetics has received from NCI since 2010, said Insight Genetics President and COO Christopher Callaghan. We are delighted that NCI continues to recognize and support our companys leadership in developing diagnostics that enable the prescription of targeted cancer therapies and our commitment to improving care for cancer patients worldwide.

Link:
Insight Genetics Awarded Two National Cancer Institute Contracts to Enhance Precision in Cancer Care

25 Multiple Sclerosis Plr Articles
ll4.me 25 Multiple Sclerosis Plr Articles 25 Multiple Sclerosis Articles - Private Label Rights Article Topics:- Treatment For Multiple Sclerosis With No Side Effects Types Of Multiple Sclerosis What Multiple Sclerotic People Should Avoid during Christmas How To Diagnose Multiple Sclerosis How To Know If It Is A Multiple Sclerosis Relapse How To Treat Multiple Sclerosis Is Cannabis Use Beneficial For Multiple Sclerosis Lifesaving Drug For Multiple Sclerosis More Information On Multiple Sclerosis Multiple Sclerosis Association Of America All About Multiple Sclerosis Causes Of Multiple Sclerosis Childbirth May Slow Multiple Sclerosis Common Human Bacteria Triggers Multiple Sclerosis Good News On Pregnancy And Multiple Sclerosis How Is Multiple Sclerosis Classified The Clinical Part Of Multiple Sclerosis The History Of Multiple Sclerosis The Kurtzke Expanded Disability Status Scale And Multiple Sclerosis Multiple Sclerosis Differential Diagnoses Not Everyone With Multiple Sclerosis Is On Treatment Pathophysiology Of Multiple Sclerosis Stem Cell Therapy Reverses Multiple Sclerosis Symptoms Of Multiple Sclerosis Teenage Obesity and Multiple Sclerosis Use the content on : Blogs/Content Pages Report Social Sites ecourses Convert to Audios ebook Bundle and Sell as Products Personal Education, Tips Training Whatever you might imagine... RIGHTS:- [YES] Can Be Sold [YES] Can Be Packaged [YES] Can Be Offered As a Bonus [YES] Can Be Added As Web Content [YES] Can Be Used For Product ...From:rebeccahenson9854Views:0 0ratingsTime:00:14More inPeople Blogs

See the original post:
25 Multiple Sclerosis Plr Articles - Video

Progenitor Cell Therapy For Neurological Injury
ll4.me Progenitor Cell Therapy For Neurological Injury Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4. Neural Stem Cells-Endogenous Repair of Neurological Injury.- Chapter 5. Traumatic Brain Injury: Pathophysiology and Models.- Chapter 6. Traumatic Brain Injury: Relationship of Clinical Injury to Progenitor Cell Therapeutics.- Chapter 7. Cell-Based Therapy for Stroke.- Chapter 8. Spinal Cord Injury: Pathophysiology and Progenitor Cell Therapy.- Chapter 9. Current Status of Clinical Trials using Progenitor Cells for Neurological Injury EAN/ISBN : 9781607619659 Publisher(s): Springer, Berlin, Springer Science Business Media Discussed keywords: Neurologie, Zelltherapie Format: ePub/PDF Author(s): Cox, Charles S. Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4From:dorethacopeland98549Views:0 0ratingsTime:00:14More inPeople Blogs

Read the original here:
Progenitor Cell Therapy For Neurological Injury - Video

Thelma before Stem Cell Therapy
From:krazykp12Views:13 0ratingsTime:01:33More inPeople Blogs

See more here:
Thelma before Stem Cell Therapy - Video

Charles - USA Stem Cells Testimonial
If you would like more information please call us Toll Free at 877-578-7908. Or visit our website at http://www.usastemcells.com Or click here to have a Free Phone Constultation with Dr. Matthew Burks usastemcells.com Real patient testimonials for USA Stem Cells. Adult stem cell therapy for COPD, Emphysema, and Pulmonary fibrosis.From:USAStemcellsViews:4 0ratingsTime:10:04More inScience Technology

Read the rest here:
Charles - USA Stem Cells Testimonial - Video

Ann Charland #39;s live cell therapy 2012
Ann Charland talking about her experience 2012 with live cell therapy by Dr. med. R. Janson-Müller (Hotel Prinzregent, Edenkoben, Germany)From:FrischzellenViews:1 0ratingsTime:00:49More inEducation

Excerpt from:
Ann Charland's live cell therapy 2012 - Video

VimedCell - The long success story of Vimed Living Cells
VimedCell, over 20 years of experience in cell therapy to the principles of Prof. Dr. Niehans. More than 5 million people have been treated successfully with living cells. VimedCell, add quality to live by staying healthy and youthful. Offering you personalised biological ageing treatment to achieve new health and vitality. Experts behind research and development with stringent quality control. VimedCell, you will be in best hands with us. http://www.vimedcell.com #1058; #1077; #1088; #1072; #1087; #1080; #1103; #1078; #1080; #1074; #1099; #1084; #1080; #1082; #1083; #1077; #1090; #1082; #1072; #1084; #1080; VimedCell -- #1101; #1090; #1086; #1094; #1077; #1083; #1086; #1089; #1090; #1085; #1099; #1081; #1080; #1085; #1089; #1090; #1088; #1091; #1084; #1077; #1085; #1090;, #1076; #1077; #1081; #1089; #1090; #1074; #1080; #1077; #1082; #1086; #1090; #1086; #1088; #1086; #1075; #1086; #1079; #1072; #1082; #1083; #1102; #1095; #1072; #1077; #1090; #1089; #1103; #1074; #1088; #1077; #1075; #1077; #1085; #1077; #1088; #1072; #1094; #1080; #1080; #1086; #1082; #1083; #1077; #1090; #1086; #1082; #1089; #1086; #1073; #1089; #1090; #1074; #1077; #1085; #1085; #1086; #1075; #1086; #1086; #1088; #1075; #1072; #1085; #1080; #1079; #1084; #1072; #1080; #1077; #1075; #1086; #1074; #1086; #1089; #1089; #1090; #1072; #1085; #1086; #1074; #1083; #1077; #1085; #1080; #1080;. http://www.vimedcell.com #1610; #1593; #1605; #1604; #1575; #1604; #1582; #1604; #1610; #1577; #1575; #1604; #1581; #1610; #1577; VimedCell #1575; #1604; #1593; #1604; #1575; #1580; #1603; #1571; #1583; #1575; #1577; #1604; #1578; #1606; #1588; #1610; #1591; #1603; #1604; #1610; #1582; #1604; #1575; #1610; #1575; #1575; #1604; #1580; #1587; #1605; #1606; #1601; #1587; #1607; #1608; #1578; #1580; #1583; #1610; #1583; #1575; #1604; #1603; #1575; #1574; #1606; #1575; #1604; #1581; #1610; #1576; #1571; #1603; #1605; #1604; #1607;. #1608; #1607; #1584; #1575; . #1610; #1593; #1606; #1610; #1571; #1606; #1571; #1587; #1604; #1608; #1576; #1575; #1604; #1593; #1604; #1575; #1580; #1610; #1583; #1593; #1605; #1602; #1583; #1585; #1577; #1575; #1604; #1588; #1582; #1589; #1593; #1604; #1609; #1575; #1604; #1578; #1580; #1583; #1583; #1608; #1610; #1593; #1586; #1586; #1581; #1610; #1608; #1610; #1578; #1607; #1575; #1575; #1604; #1582; #1575; #1589; #1577;. VimedCell #27963; #32454; #32990; #30103; #27861; #21487; #20316; #20026; #20351; #26426; #20307; #33258; #36523; #32454; #32990; #37325; #33719; #29983; #21629; #21147; #24182; #20351; #25972; #20010; #26426; #20307; #20877; #29983; #30340; #25972; #20307; #24037; #20855; #32780; #20351; #29992; #12290; #36825; #24847; #21619; #30528; #35813; #30103; #27861; #25903; #25345; #20154; #33258; #24049; #30340; #20877; #29983; #33021; #21147; #24182; #22686; #24378; #26426; #20307; #27963; #21147; #12290;www.vimedcell.com A VimedCell Living Cell Therapy é empregada como uma ferramenta holística para revitalizar as próprias células do corpo e regenerar o organismo inteiro. http://www.vimedcell.com La thérapie VimedCell cellule vivante est utilisée comme un outil complet pour revitaliser les propres cellules de l #39;organisme et régénérer l #39;organisme tout entier. http://www.vimedcell.comFrom:vimedcellViews:1 0ratingsTime:02:58More inPeople Blogs

See the rest here:
VimedCell - The long success story of Vimed Living Cells - Video

SHIMMIAN MANILA - Celebs share good effects of stem cell therapy
From:myrenovatiosolutionsViews:1 0ratingsTime:01:30More inEntertainment

Read this article:
SHIMMIAN MANILA - Celebs share good effects of stem cell therapy - Video

By Philip C. Tubeza Philippine Daily Inquirer

The Department of Health (DOH) on Saturday warned those contemplating stem cell therapy against using stem cells from aborted babies and human embryos.

The DOH issued the statement as it reviewed the legal and technical specifications of stem cell therapy to come up with a regulatory framework.

The Philippine government will not allow the use of aborted fetuses or human embryos (as sources of stem cells). There is a need to ensure that the biological raw materials are documented and validated and follow infection-free procedures, the health department said.

There is also a need to know if the materials to be injected came from animal or human tissues, it added.

The DOH said the other fundamental areas of the regulatory framework would include the monitoring of the marketing claims by medical centers that offer stem cell therapy so that the claims stick within the boundaries of science as objectively as possible.

Credentials and procedures

The credentials of the scientists involved should also match the training, education and skills required for these procedures while good laboratory procedures should be observed in the preparation of the tissue and cells, the DOH said.

The centers to be regulated or accredited will have to show both positive and negative outcomes for a better handle of the predictors of success or failure from this intervention, it said.

The health department said there was a need for a regulatory framework because there were many steps in the preparation of stem cell therapies and the government had been receiving many queries about it.

Read the rest here:
DOH warns against use of stem cells from aborted babies

Washington, Nov. 9 (ANI)

Mutations in a single gene - that causes intellectual disability and increases the risk of developing autism spectrum disorder - severely disrupts the organization of developing brain circuits during early childhood, a new study has revealed.

This study by scientists from the Florida campus of The Scripps Research Institute helps explain how genetic mutations can cause profound cognitive and behavioural problems.

"In this study, we did something no one else had done before," Gavin Rumbaugh, a TSRI associate professor who led the new research, said.

"Using an animal model, we looked at a mutation known to cause intellectual disability and showed for the first time a causative link between abnormal synapse maturation during brain development and life-long cognitive disruptions commonly seen in adults with a neurodevelopmental disorder," he said.

The study focused on a critical synaptic protein known as SynGAP1.

Mutations in the gene that encodes this protein cause disabilities in an estimated one million people worldwide, according to the paper.

"You might think this accelerated development of brain circuits would make you smarter," Rumbaugh said.

"But the increased excitability actually disorganizes brain development. We think that early maturation of these excitatory synapses disrupts the timing of later developmental milestones. It rains down chaos on this complex process, preventing normal intellectual and behavioural development," he said.

The study has been published in the journal Cell.

View post:
Gene mutation behind brain defects identified

THURSDAY, Nov. 8 (HealthDay News) -- Specific DNA variations explain more than 10 percent of the inherited genetic risk for developing heart disease, a new study suggests.

Researchers discovered 20 previously unidentified genetic variations in more than 63,000 people with coronary artery disease, which causes more deaths worldwide than any other disease.

These variations were uncommon in a control group of more than 130,000 people without heart disease.

The newly identified mutations bring to 47 the total number of genetic variations that have so far been linked to an increased risk for developing heart disease, according to study co-leader Panos Deloukas, head of the Genetics of Complex Traits in Humans research group at the Wellcome Trust Sanger Institute, in Cambridge, England.

One previous study estimated that 30 percent to 60 percent of heart disease cases might be attributable to genetic risk factors. This new study increases the number of genes likely involved in coronary artery disease.

The study was to be presented Thursday at the American Society of Human Genetics annual meeting in San Francisco.

"We no longer assume that coronary heart disease is triggered by just a handful of genes, each with a strong effect on a person's risk for the disease," Deloukas said in a society news release. "Our research supports the current assumption that heart disease risk is determined by a large group of genes, each with a modest effect on risk."

Deloukas said pinpointing the genetic variations involved in coronary artery disease may lead to improved treatments, and noted that many of the newly identified variations are in genes involved in the body's metabolism of fats as well as in inflammation.

The findings highlight the roles of high cholesterol levels and inflammation in coronary artery disease, Deloukas said.

Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

Here is the original post:
More Gene Variants Linked to Heart Trouble